BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23865151)

  • 1. What are the new therapeutic alternatives to warfarin in atrial fibrillation?
    Kamran SH; Muzammil SM; Kamal AK
    J Pak Med Assoc; 2013 Jan; 63(1):129-30. PubMed ID: 23865151
    [No Abstract]   [Full Text] [Related]  

  • 2. A new era for anticoagulation in atrial fibrillation.
    Mega JL
    N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial fibrillation choices. Picking an anti-clotting drug.
    Mayo Clin Health Lett; 2014 Jun; 32(6):4-5. PubMed ID: 25029747
    [No Abstract]   [Full Text] [Related]  

  • 4. Help prevent Afib-related stroke. New anticoagulants for atrial fibrillation prove as effective, or even better than, warfarin--and easier to use.
    Duke Med Health News; 2014 Sep; 20(9):3. PubMed ID: 25358137
    [No Abstract]   [Full Text] [Related]  

  • 5. Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
    Stöllberger C; Finsterer J
    Thromb Haemost; 2013 Sep; 110(3):496-500. PubMed ID: 23803875
    [No Abstract]   [Full Text] [Related]  

  • 6. Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
    Diener HC
    Thromb Haemost; 2013 Sep; 110(3):493-5. PubMed ID: 23803957
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel anticoagulants eliminate the need for left atrial appendage exclusion devices.
    Ezekowitz MD; Kent AP
    Circulation; 2014 Oct; 130(17):1505-14. PubMed ID: 25332278
    [No Abstract]   [Full Text] [Related]  

  • 8. A new era of antithrombotic therapy in patients with atrial fibrillation.
    Golwala H; Dib C; Tafur A; Abu-Fadel MS
    Am J Med Sci; 2012 Aug; 344(2):128-35. PubMed ID: 22245946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New agents to prevent strokes in nonvalvular atrial fibrillation.
    Putney D; Pratt C
    Methodist Debakey Cardiovasc J; 2012; 8(3):44-6. PubMed ID: 23227289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP; Halperin JL
    Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of atrial fibrillation.
    Med Lett Drugs Ther; 2014 Jul; 56(1446):53-8. PubMed ID: 25046325
    [No Abstract]   [Full Text] [Related]  

  • 13. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
    Ahrens I; Lip GY; Peter K
    Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T; Levin V; Martinez MW; Marchlinski FE
    Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition from apixaban to warfarin--addressing excess stroke, systemic embolism, and major bleeding.
    Cairns JA; Weitz JI
    Am Heart J; 2015 Jan; 169(1):1-3. PubMed ID: 25497240
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012.
    Truffa AA; Lopes RD; Newby LK
    Postgrad Med; 2013 Mar; 125(2):146-57. PubMed ID: 23816780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
    Kosar L; Jin M; Kamrul R; Schuster B
    Can Fam Physician; 2012 Aug; 58(8):850-8. PubMed ID: 22893338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.